BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19995670)

  • 1. Preliminary effects of bupropion and the promoter region (HTTLPR) serotonin transporter (SLC6A4) polymorphism on smoking behavior in schizophrenia.
    Bloch B; Reshef A; Cohen T; Tafla A; Gathas S; Israel S; Gritsenko I; Kremer I; Ebstein RP
    Psychiatry Res; 2010 Jan; 175(1-2):38-42. PubMed ID: 19995670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia.
    Evins AE; Mays VK; Rigotti NA; Tisdale T; Cather C; Goff DC
    Nicotine Tob Res; 2001 Nov; 3(4):397-403. PubMed ID: 11694208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of serotonin transporter promoter gene polymorphism (5-HTTLPR) with depression in Costa Rican schizophrenic patients.
    Contreras J; Hernández S; Quezada P; Dassori A; Walss-Bass C; Escamilla M; Raventos H
    J Neurogenet; 2010 Jul; 24(2):83-9. PubMed ID: 20397838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between 5-hydroxytryptamine transporter gene-linked polymorphic region and smoking behavior in Chinese males.
    Chu SL; Xiao D; Wang C; Jing H
    Chin Med J (Engl); 2009 Jun; 122(12):1365-8. PubMed ID: 19567154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No association of serotonin transporter polymorphism (5-HTTVNTR and 5-HTTLPR) with characteristics and treatment response to atypical antipsychotic agents in schizophrenic patients.
    Lee HY; Kim DJ; Lee HJ; Choi JE; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):276-80. PubMed ID: 19059448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The serotonin transporter gene polymorphism is not associated with smoking behavior.
    Trummer O; Köppel H; Wascher TC; Grünbacher G; Gutjahr M; Stanger O; Ramschak-Schwarzer S; Boehm BO; Winkelmann BR; März W; Renner W
    Pharmacogenomics J; 2006; 6(6):397-400. PubMed ID: 16702982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between the serotonin transporter gene (5-HTTLPR) and anger-related traits in Korean schizophrenic patients.
    Kim YR; Jahng JW; Min SK
    Neuropsychobiology; 2009; 59(3):165-71. PubMed ID: 19439997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin transporter gene promoter polymorphism and somatoform symptoms.
    Hennings A; Zill P; Rief W
    J Clin Psychiatry; 2009 Nov; 70(11):1536-9. PubMed ID: 19538902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation.
    Johnston JA; Fiedler-Kelly J; Glover ED; Sachs DP; Grasela TH; DeVeaugh-Geiss J
    Nicotine Tob Res; 2001 May; 3(2):131-40. PubMed ID: 11403727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variants in the serotonin transporter influence the efficacy of bupropion and nortriptyline in smoking cessation.
    Quaak M; van Schayck CP; Postma DS; Wagena EJ; van Schooten FJ
    Addiction; 2012 Jan; 107(1):178-87. PubMed ID: 21658141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bupropion and cognitive-behavioral therapy for smoking cessation in women.
    Schmitz JM; Stotts AL; Mooney ME; Delaune KA; Moeller GF
    Nicotine Tob Res; 2007 Jun; 9(6):699-709. PubMed ID: 17558827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catechol-O-methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence.
    Berrettini WH; Wileyto EP; Epstein L; Restine S; Hawk L; Shields P; Niaura R; Lerman C
    Biol Psychiatry; 2007 Jan; 61(1):111-8. PubMed ID: 16876132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling.
    Collins BN; Wileyto EP; Patterson F; Rukstalis M; Audrain-McGovern J; Kaufmann V; Pinto A; Hawk L; Niaura R; Epstein LH; Lerman C
    Nicotine Tob Res; 2004 Feb; 6(1):27-37. PubMed ID: 14982685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
    Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression.
    Maron E; Tammiste A; Kallassalu K; Eller T; Vasar V; Nutt DJ; Metspalu A
    Eur Neuropsychopharmacol; 2009 Jun; 19(6):451-6. PubMed ID: 19272758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter, randomized, double-blind, placebo-controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees.
    Dalsgareth OJ; Hansen NC; Søes-Petersen U; Evald T; Høegholm A; Barber J; Vestbo J
    Nicotine Tob Res; 2004 Feb; 6(1):55-61. PubMed ID: 14982688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of pharmacotherapy and behavioral interventions for smoking cessation in actual clinical practice.
    Rovina N; Nikoloutsou I; Katsani G; Dima E; Fransis K; Roussos C; Gratziou C
    Ther Adv Respir Dis; 2009 Dec; 3(6):279-87. PubMed ID: 19934280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No evidence for a major role of polymorphisms during bupropion treatment.
    Hu J; Redden DT; Berrettini WH; Shields PG; Restine SL; Pinto A; Lerman C; Allison DB
    Obesity (Silver Spring); 2006 Nov; 14(11):1863-7. PubMed ID: 17135598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin transporter gene polymorphism (5-HTTLPR) in patients with oral lichen planus.
    Perdigão PF; Guimarães AL; Victoria JM; Xavier GM; Romano-Silva MA; Gomez RS
    Arch Oral Biol; 2007 Sep; 52(9):889-93. PubMed ID: 17359932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.